Viewing Study NCT02015169


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-02-22 @ 7:07 AM
Study NCT ID: NCT02015169
Status: COMPLETED
Last Update Posted: 2018-01-17
First Post: 2013-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Sponsor:
Organization: